We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Robust Home Secretary action has driven an almost 80% fall in student dependant applications in the first quarter of 2024 compared to the same period in 2023.
Guidance on how to license electronic cigarettes and other inhaled nicotine-containing products (NCPs) as medicines in the UK.
Pharmacy, prescription-only (POM), and general sale list (GSL) medicines: apply to move your medicine to a different classification.
How to use a cost effectiveness analysis to evaluate your digital health product.
How offender healthcare is managed in prisons and in the community.
Seeking to improve the performance of the non-state sector in delivering better healthcare to the poor.
Facts, resources and information on major public health issues for public health professionals, local authorities and CCG commissioners.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
How to get fast-track approval of medical devices during COVID-19.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Provides actions that employers in general, local authorities, and the NHS workforce can take with regards to health and work.
How to use a cost benefit analysis to evaluate your digital health product.
Information and guidance on a range of medical devices for users and patients.
The MHRA is ready to provide any assistance for clinical trials applications submitted for COVID-19
This consultation seeks views on different ways in which government and employers can take action to reduce ill health-related job loss.
How investigators and sponsors should manage clinical trials during COVID-19
How to use an economic evaluation to evaluate your digital health product.
Foreign, Commonwealth & Development Office (FCDO) advice for lesbian, gay, bisexual and transgender (LGBT+) people travelling abroad.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
Chief Medical Officer for England, Professor Chris Whitty's annual reports and lectures on medicine and public health.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.